Effect of IL‐5, glucocorticoid, and Fas ligation on Bcl‐2 homologue expression and caspase activation in circulating human eosinophils

IL‐5 is a potent eosinophil viability‐enhancing factor that has been strongly implicated in the pathogenesis of IgE‐mediated inflammation in vivo. Recently published data have suggested that IL‐5 (and related cytokines) may act by altering the expression of the anti‐apoptotic regulator Bcl‐2 or its homologues, but this is controversial. The behaviour of the recently described pro‐apoptotic cysteine proteases (caspases) in eosinophils after IL‐5 treatment has not been explored. We examined the effect of IL‐5 on the expression of four major Bcl‐2 homologues, as well as on the expression/activation of key members of the caspase cell death cascade in cultured circulating human eosinophils. The effect of relevant inducers of eosinophil apoptosis (glucocorticoid and Fas ligation) on these regulatory proteins was also examined. We observed baseline expression of the anti‐apoptotic Mcl‐1 and pro‐apoptotic Bax proteins in immunoblots of eosinophil lysates, but not Bcl‐x, Bcl‐2. IL‐5 treatment had the effect of maintaining this basal level of expression over time without altering the balance of Bcl‐2 homologues. The (upstream) caspase 8 and (downstream) caspase 3 proenzymes were detected in eosinophils at baseline, and were processed during spontaneous and stimulated eosinophil death. IL‐5 completely blocked caspase processing in spontaneous and dexamethasone‐induced cell death, and significantly slowed processing during Fas ligation. Our data do not support the theory that IL‐5 acts by altering the balance of anti‐apoptotic and pro‐apoptotic Bcl‐2 homologues, but suggest that it may act by regulating activation of the caspase cell death cascade.

[1]  A. Wardlaw,et al.  Expression of Bcl-2 and its homologues in human eosinophils. Modulation by interleukin-5. , 1999, American journal of respiratory cell and molecular biology.

[2]  S. Srinivasula,et al.  Cascades of Mammalian Caspase Activation in the YeastSaccharomyces cerevisiae * , 1999, The Journal of Biological Chemistry.

[3]  Y. Lazebnik,et al.  Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  I. Tillie‐Leblond,et al.  Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. , 1998, American journal of respiratory cell and molecular biology.

[5]  K. Rabe,et al.  Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. , 1998, American journal of respiratory cell and molecular biology.

[6]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[7]  H. Simon,et al.  Role for Bcl-xL in Delayed Eosinophil Apoptosis Mediated by Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-5 , 1998 .

[8]  M. Arock,et al.  Human eosinophils express bcl-2 family proteins: modulation of Mcl-1 expression by IFN-gamma. , 1998, American journal of respiratory cell and molecular biology.

[9]  D G Kirsch,et al.  Modulation of cell death by Bcl-XL through caspase interaction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Cheng,et al.  Conversion of Bcl-2 to a Bax-like death effector by caspases. , 1997, Science.

[11]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[12]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[13]  F Gambale,et al.  Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.

[14]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[15]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[16]  E. Alnemri.  Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases , 1997, Journal of cellular biochemistry.

[17]  R. Matsumura,et al.  IL‐5 but not interferon‐gamma (IFN‐γ) inhibits eosinophil apoptosis by up‐regulation of bcl‐2 expression , 1997, Clinical and experimental immunology.

[18]  H. Simon,et al.  Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. , 1997, International archives of allergy and immunology.

[19]  S. Srinivasula,et al.  Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Srinivasula,et al.  The Ced-3/Interleukin 1β Converting Enzyme-like Homolog Mch6 and the Lamin-cleaving Enzyme Mch2α Are Substrates for the Apoptotic Mediator CPP32* , 1996, The Journal of Biological Chemistry.

[21]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[22]  R. Egan,et al.  Biology of interleukin‐5 and its relevance to allergic disease , 1996, Allergy.

[23]  H. Magnussen,et al.  The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. , 1996, American journal of respiratory and critical care medicine.

[24]  Z. Oltvai,et al.  Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Matsumoto,et al.  Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. , 1995, Blood.

[26]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[27]  S. Korsmeyer,et al.  Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.

[28]  E. Alnemri,et al.  CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. , 1994, The Journal of biological chemistry.

[29]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[30]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[31]  R. Craig,et al.  MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Busse,et al.  IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. , 1993, The American review of respiratory disease.

[33]  K. Blaser,et al.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.

[34]  W. Owen,et al.  Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. , 1991, The Journal of clinical investigation.

[35]  T. Suda,et al.  Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. , 1991, Blood.

[36]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[37]  R. Coffman,et al.  Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. , 1989, Science.

[38]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.